Common approach in the Baltics to introduction of additional safety features on medicinal product packages

Common approach in the Baltics to introduction of additional safety features on medicinal product packages

Today, on 20 October 2016, the annual meeting of experts from the Baltic state agencies of medicines is taking place in Riga in order to discuss the normative regulation of the pharmaceutical field and the latest developments within the industry. The meeting agenda included a review of the trends in consumption of medicines in the Baltic States, safety issues of medicines and additional safety features on medicinal product packages, as well as solutions for issues regarding disruptions in supply of medicines.

Participants of the meeting of the state agencies of medicines in the Baltic States

Representatives of the state agencies of medicines in Latvia, Estonia and Lithuania meet every year to discuss pharmaceutical regulatory issues. The collaboration between the Baltic States is important not only from a regional unity perspective, but also due to the importance of establishing stable conditions for all the participants in the markets of smaller countries. On 22 November 2012 three directors of state agencies of medicines of the Baltic States signed an agreement in Riga to ensure collaboration in the areas of good manufacturing practice, good distribution practice, good pharmacovigilance practice and good clinical practice, as well as collaboration of the laboratories in the Baltic States with regard to testing of medicines authorised via the national procedure. Read more